Literature DB >> 22669215

Cortical blindness and posterior reversible encephalopathy syndrome in an older patient.

Sabrina Ait1, Thomas Gilbert, Francois Cotton, Marc Bonnefoy.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a clinical and radiological entity. It associates, to varying extents, neurological symptoms such as headaches, confusion, seizures and visual alterations from haemianopsia to cortical blindness. The diagnosis relies on brain MRI, showing signs of subcortical and cortical oedema in the posterior regions of the brain, with hypersignals in T2/fluid attenuated inversion recovery (FLAIR) or diffusion sequences. With early diagnosis and control of the causal factors, the symptoms and radiological signs can be - as the name implies - totally regressive. PRES can be caused by various heterogeneous factors, such as hypertension, side effect of drug therapies, eclampsia, sepsis or autoimmune diseases. The authors report here the case of an 86-year-old woman, presenting totally regressive cortical blindness and seizures, with compatible imaging.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22669215      PMCID: PMC3369388          DOI: 10.1136/bcr.09.2011.4782

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  17 in total

1.  Intravenous immunoglobulin causing reversible posterior leukoencephalopathy syndrome?

Authors:  M Lewis; P Maddison
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-11       Impact factor: 10.154

2.  [Reversible posterior leucoencephalopathy syndrome].

Authors:  I Bonnaud; J-P Cottier
Journal:  Rev Neurol (Paris)       Date:  2004-03       Impact factor: 2.607

3.  Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings.

Authors:  Jennifer E Fugate; Daniel O Claassen; Harry J Cloft; David F Kallmes; Osman S Kozak; Alejandro A Rabinstein
Journal:  Mayo Clin Proc       Date:  2010-05       Impact factor: 7.616

4.  [Patient with posterior reversible encephalopathy syndrome with prolonged disturbance of consciousness and convulsion after cerebral aneurysm surgery].

Authors:  Kayo Ueda; Takuo Hoshi; Shinko Yorozu; Junko Okazaki; Yuji Motomura; Tomohiko Masumoto; Tsunehisa Tsubokawa; Makoto Tanaka
Journal:  Masui       Date:  2011-02

5.  Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors.

Authors:  Molly M Burnett; Christopher P Hess; John P Roberts; Nathan M Bass; Vanja C Douglas; S Andrew Josephson
Journal:  Clin Neurol Neurosurg       Date:  2010-08-25       Impact factor: 1.876

Review 6.  Cortical blindness: clinical and radiologic findings in reversible posterior leukoencephalopathy syndrome: case report and review of the literature.

Authors:  Alon Kahana; Howard A Rowley; Joel M Weinstein
Journal:  Ophthalmology       Date:  2005-02       Impact factor: 12.079

7.  Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance?

Authors:  Christina Mueller-Mang; Thomas Mang; Agnes Pirker; Katharina Klein; Christine Prchla; Daniela Prayer
Journal:  Neuroradiology       Date:  2009-02-21       Impact factor: 2.804

8.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

9.  Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients.

Authors:  J M Baehring; R K Fulbright
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-08-06       Impact factor: 10.154

10.  Differentiation of cytotoxic and vasogenic edema in a patient with reversible posterior leukoencephalopathy syndrome using diffusion-weighted MRI.

Authors:  Marc Doelken; Stefan Lanz; Janine Rennert; Sedat Alibek; Gregor Richter; Arnd Doerfler
Journal:  Diagn Interv Radiol       Date:  2007-09       Impact factor: 2.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.